All Phenotypes Ptch2<tm1Pmc> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Ptch2^tm1Pmc
targeted mutation 1, Peter J McKinnon
MGI:3665289

Summary

5 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Ptch2^tm1Pmc/Ptch2^tm1Pmc	involves: 129S1/Sv * C57BL/6	MGI:3690364
cx2	Ptch1^tm1Mps/Ptch1⁺ Ptch2^tm1Pmc/Ptch2⁺ Trp53^tm1Tyj/Trp53^tm1Tyj	involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6	MGI:3690370
cx3	Ptch2^tm1Pmc/Ptch2^tm1Pmc Trp53^tm1Tyj/Trp53^tm1Tyj	involves: 129S1/Sv * 129S2/SvPas * C57BL/6	MGI:3690369
cx4	Ptch1^tm1Mps/Ptch1⁺ Ptch2^tm1Pmc/Ptch2⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:3690366
cx5	Ptch1^tm1Mps/Ptch1⁺ Ptch2^tm1Pmc/Ptch2^tm1Pmc	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:3690367

Allelic Composition	Ptch2^tm1Pmc/Ptch2^tm1Pmc
Genetic Background	involves: 129S1/Sv * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptch2^tm1Pmc mutation (0 available); any Ptch2 mutation (47 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

normal phenotype

no abnormal phenotype detected ( J:112118 )

• mutants are viable and apparently normal; no differences are observed in cell proliferation or differentiation in the cerebellum

Allelic Composition	Ptch1^tm1Mps/Ptch1⁺ Ptch2^tm1Pmc/Ptch2⁺ Trp53^tm1Tyj/Trp53^tm1Tyj
Genetic Background	involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptch1^tm1Mps mutation (2 available); any Ptch1 mutation (115 available)
Ptch2^tm1Pmc mutation (0 available); any Ptch2 mutation (47 available)
Trp53^tm1Tyj mutation (12 available); any Trp53 mutation (232 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

neoplasm ( J:112118 )

N	• mice show no increase in tumor incidence compared to Ptch1/Trp53 double null mice

Allelic Composition	Ptch2^tm1Pmc/Ptch2^tm1Pmc Trp53^tm1Tyj/Trp53^tm1Tyj
Genetic Background	involves: 129S1/Sv * 129S2/SvPas * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptch2^tm1Pmc mutation (0 available); any Ptch2 mutation (47 available)
Trp53^tm1Tyj mutation (12 available); any Trp53 mutation (232 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

neoplasm ( J:112118 )

N	• double mutants show similar tumor profile and latency as Trp53-null animals (11/20 develop thymoma and/or sarcoma by 4 months of age)

Allelic Composition	Ptch1^tm1Mps/Ptch1⁺ Ptch2^tm1Pmc/Ptch2⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased testicular teratoma incidence ( J:112118 )

• 2/54 males develop testicular teratomas

increased basal cell carcinoma incidence ( J:112118 )

• frequency is greater (3/63) compared to Ptch1-deficient mice (1/62)

increased rhabdomyosarcoma incidence ( J:112118 )

• incidence is increased in frequency

decreased tumor latency ( J:112118 )

• 50% develop tumors by 5 months of age, compared to ~15% of Ptch1-heterozygous, Ptch2-sufficient mice develop tumors by 12 months of age

cardiovascular system

telangiectasia ( J:112118 )

• subcutaneous telangiectasia is observed in 2% of mice

digestive/alimentary system

abnormal intestine morphology ( J:112118 )

• ~19% of mice display intestinal serosal angiectasis

muscle

telangiectasia ( J:112118 )

• subcutaneous telangiectasia is observed in 2% of mice

increased rhabdomyosarcoma incidence ( J:112118 )

• incidence is increased in frequency

integument

increased basal cell carcinoma incidence ( J:112118 )

• frequency is greater (3/63) compared to Ptch1-deficient mice (1/62)

endocrine/exocrine glands

increased testicular teratoma incidence ( J:112118 )

• 2/54 males develop testicular teratomas

reproductive system

increased testicular teratoma incidence ( J:112118 )

• 2/54 males develop testicular teratomas

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
medulloblastoma		DOID:0050902	OMIM:155255	J:112118

Allelic Composition	Ptch1^tm1Mps/Ptch1⁺ Ptch2^tm1Pmc/Ptch2^tm1Pmc
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:112118 )

• increased tumorigenesis is readily apparent in 6th-generation compound mutants

increased basal cell carcinoma incidence ( J:112118 )

• frequency is greater (5/97) compared to Ptch1-deficient mice (1/62)

increased rhabdomyosarcoma incidence ( J:112118 )

• incidence is increased in frequency

increased medulloblastoma incidence ( J:112118 )

• occur with higher frequency

decreased tumor latency ( J:112118 )

• 50% develop tumors by 10 months of age, compared to ~15% of Ptch1-heterozygous, Ptch2-sufficient mice develop tumors by 12 months of age

digestive/alimentary system

abnormal intestine morphology ( J:112118 )

• ~18% of mice display intestinal serosal angiectasis

integument

increased basal cell carcinoma incidence ( J:112118 )

• frequency is greater (5/97) compared to Ptch1-deficient mice (1/62)

nervous system

increased medulloblastoma incidence ( J:112118 )

• occur with higher frequency

muscle

increased rhabdomyosarcoma incidence ( J:112118 )

• incidence is increased in frequency

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
medulloblastoma		DOID:0050902	OMIM:155255	J:112118

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/23/2024 MGI 6.23